Equities

Genmark Diagnostics Inc

Genmark Diagnostics Inc

Actions
  • Price (USD)14.87
  • Today's Change0.18 / 1.23%
  • Shares traded662.97k
  • 1 Year change+200.40%
  • Beta2.9257
Data delayed at least 15 minutes, as of Jan 20 2021 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

    Key statistics

    On Wednesday, Genmark Diagnostics Inc (GNMK:NMQ) closed at 14.87, -28.78% below its 52-week high of 20.88, set on Aug 05, 2020.
    52-week range
    Today
    3.36Mar 02 202020.88Aug 05 2020
    Markit short selling activity
    Low
    Med
    High
    Open14.75
    High15.05
    Low14.62
    Bid14.50
    Offer20.00
    Previous close14.87
    Average volume866.76k
    Shares outstanding71.72m
    Free float68.66m
    P/E (TTM)--
    Market cap1.07bn USD
    EPS (TTM)-0.4059
    USD
    Data delayed at least 15 minutes, as of Jan 20 2021 21:00 GMT.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.